TCAs, noradrenaline and 5-HT reuptake inhibitors, such as desipramine and nortriptyline demonstrated clinic superiority for PD-associated depression over, respectively, the SSRIs citalopram and paroxetine [59,60]. This evidence concerns the gene HTR5A and Parkinson disease.